Pathogenic Variants and Olipudase Alfa Treatment of Patients With Acid Sphingomyelinase Deficiency in Taiwan
This study highlights distinct genotype-phenotype correlations in ASMD and supports the clinical benefits of olipudase alfa. Increased awareness and early diagnosis, potentially through newborn screening, are essential for optimizing outcomes in ASMD.
Authors
- Steven Shinn‐Forng Peng (ORCID: https://orcid.org/0000-0002-8177-5187)
- Rai‐Hseng Hsu (ORCID: https://orcid.org/0000-0002-4510-9953)
- Yen‐Yin Chou (ORCID: https://orcid.org/0000-0003-3599-2284)
- Hui‐An Chen (ORCID: https://orcid.org/0000-0003-2103-9062)
- Shyh‐Jer Lin
- Pao‐Chin Chiu
- Wuh‐Liang Hwu
- Yin‐Hsiu Chien
- Hsu‐Heng Lin
- Yen‐Hsuan Ni
- Ni‐Chung Lee
Institutions
- Kaohsiung Medical University (TW)
- National Taiwan University (TW)
- China Medical University (TW)
- China Medical University Hospital (TW)
- National Taiwan University Hospital (TW)
- Kaohsiung Veterans General Hospital (TW)
- National Cheng Kung University Hospital (TW)
- Changhua Christian Hospital (TW)
Publication Details
- Journal
- Molecular Genetics & Genomic Medicine
- Published
- 2026-02-01
- DOI
- https://doi.org/10.1002/mgg3.70204
- Primary Topic
- Lysosomal Storage Disorders Research
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Sanofi
- National Taiwan University Hospital
- National Taiwan University
- Kaohsiung Veterans General Hospital